News & Updates

AFP Maternal Serum Screening Risks

By Sofia Laurent 154 Views
AFP Maternal Serum ScreeningRisks
AFP Maternal Serum Screening Risks

It is the role of the obstetrician to correlate these results with ultrasound findings to provide an accurate assessment. A level that is too high might indicate a neural tube defect, while a level that is too low could suggest a risk for chromosomal abnormalities.

Understanding AFP Maternal Serum Screening Risks and Limitations

Conversely, false-negative results are possible, meaning that a person with liver cancer might still have AFP levels within the normal range. Limitations and Considerations It is important to recognize that an AFP test is not foolproof.

Use in Pregnancy Monitoring Fetal Development and Screening During pregnancy, AFP screening is a standard component of prenatal care, usually performed between the 15th and 20th weeks of gestation. Clinical Significance in Oncology In the context of cancer, AFP is most commonly associated with hepatocellular carcinoma (HCC), which is the most prevalent form of liver cancer.

AFP Maternal Serum Screening Risks and Limitations

Understanding AFP levels is essential for clinicians when screening for and monitoring specific diseases, particularly those affecting the liver and reproductive system. Elevated or suppressed levels can signal the need for further investigation into hepatic or oncological conditions.

More About Afp in medical terms

Looking at Afp in medical terms from another angle can help expand the discussion and give readers a second clear paragraph under the same section.

More perspective on Afp in medical terms can make the topic easier to follow by connecting earlier points with a few simple takeaways.

S

Written by Sofia Laurent

Sofia Laurent is a Senior Editor exploring design, lifestyle, and global trends. She blends editorial clarity with a refined point of view.